PT Kimia Farma Tbk (ISX:KAEF) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


ISX:KAEF PT Kimia Farma Tbk ISX:KAEF
56 GF Score
Price Rp466.00
GF Value Rp581.98
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Tbk Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

PT Kimia Farma Tbk's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

ISX:KAEF vs MCK, COR, CAH: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Distribution subindustry, PT Kimia Farma Tbk's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Kimia Farma Tbk Margin of Safety % (DCF Earnings Based) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Tbk's Margin of Safety % (DCF Earnings Based) falls into.


ISX:KAEF
56GF Score
PT Kimia Farma Tbk ISX:KAEF
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Kimia Farma Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Tbk stock appears to be undervalued. The current stock price of Rp466.00 is trading 19.9% below its estimated GF Value™ of Rp581.98. GuruFocus considers PT Kimia Farma Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: Rp581.98 vs. price of Rp466.00 (19.9% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Kimia Farma Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
56GF Score

Get the complete analysis for ISX:KAEF

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp466.00
Price
Rp581.98
GF Value